Edgewise Therapeutics, Inc.

NasdaqGS:EWTX 株式レポート

時価総額：US$3.0b

Edgewise Therapeutics マネジメント

マネジメント 基準チェック /44

Edgewise Therapeuticsの CEO はKevin Kochで、 Aug2017年に任命され、 の在任期間は 7.25年です。 の年間総報酬は$ 3.98Mで、 15%給与と85%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.37%を直接所有しており、その価値は$ 11.38M 。経営陣と取締役会の平均在任期間はそれぞれ4.2年と4.8年です。

主要情報

Kevin Koch

最高経営責任者

US$4.0m

報酬総額

CEO給与比率15.0%
CEO在任期間7.3yrs
CEOの所有権0.4%
経営陣の平均在職期間4.2yrs
取締役会の平均在任期間4.8yrs

経営陣の近況

Recent updates

Here's Why We're Not Too Worried About Edgewise Therapeutics' (NASDAQ:EWTX) Cash Burn Situation

Nov 26
Here's Why We're Not Too Worried About Edgewise Therapeutics' (NASDAQ:EWTX) Cash Burn Situation

Edgewise: Stock Is Bouncing On Heart Disease Drug Data, Albeit From Just 7 Patients (Rating Upgrade)

Sep 19

We Think Edgewise Therapeutics (NASDAQ:EWTX) Can Afford To Drive Business Growth

Aug 12
We Think Edgewise Therapeutics (NASDAQ:EWTX) Can Afford To Drive Business Growth

Edgewise Therapeutics: Strong Open Label Data Makes For A Bullish Signal

Aug 05

Edgewise: Intriguing Drug Candidate, But Consider Selling After Recent Run

May 10

We're Not Very Worried About Edgewise Therapeutics' (NASDAQ:EWTX) Cash Burn Rate

May 10
We're Not Very Worried About Edgewise Therapeutics' (NASDAQ:EWTX) Cash Burn Rate

Edgewise Therapeutics: Behind The Massive Rally

Feb 18

Companies Like Edgewise Therapeutics (NASDAQ:EWTX) Are In A Position To Invest In Growth

Dec 07
Companies Like Edgewise Therapeutics (NASDAQ:EWTX) Are In A Position To Invest In Growth

Edgewise Therapeutics (NASDAQ:EWTX) Is In A Good Position To Deliver On Growth Plans

Aug 16
Edgewise Therapeutics (NASDAQ:EWTX) Is In A Good Position To Deliver On Growth Plans

Companies Like Edgewise Therapeutics (NASDAQ:EWTX) Are In A Position To Invest In Growth

Apr 28
Companies Like Edgewise Therapeutics (NASDAQ:EWTX) Are In A Position To Invest In Growth

We Think Edgewise Therapeutics (NASDAQ:EWTX) Can Afford To Drive Business Growth

Jan 13
We Think Edgewise Therapeutics (NASDAQ:EWTX) Can Afford To Drive Business Growth

Edgewise Therapeutics proposes $100M stock offering plan

Sep 13

Edgewise Therapeutics GAAP EPS of -$0.32 beats by $0.02

Aug 04

Companies Like Edgewise Therapeutics (NASDAQ:EWTX) Are In A Position To Invest In Growth

Aug 02
Companies Like Edgewise Therapeutics (NASDAQ:EWTX) Are In A Position To Invest In Growth

We're Hopeful That Edgewise Therapeutics (NASDAQ:EWTX) Will Use Its Cash Wisely

Mar 24
We're Hopeful That Edgewise Therapeutics (NASDAQ:EWTX) Will Use Its Cash Wisely

We're Hopeful That Edgewise Therapeutics (NASDAQ:EWTX) Will Use Its Cash Wisely

Nov 23
We're Hopeful That Edgewise Therapeutics (NASDAQ:EWTX) Will Use Its Cash Wisely

Edgewise Therapeutics names new chief medical officer

Apr 27

CEO報酬分析

Edgewise Therapeutics の収益と比較して、Kevin Koch の報酬はどのように変化したか？
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$124m

Jun 30 2024n/an/a

-US$116m

Mar 31 2024n/an/a

-US$106m

Dec 31 2023US$4mUS$595k

-US$100m

Sep 30 2023n/an/a

-US$89m

Jun 30 2023n/an/a

-US$81m

Mar 31 2023n/an/a

-US$76m

Dec 31 2022US$5mUS$572k

-US$68m

Sep 30 2022n/an/a

-US$61m

Jun 30 2022n/an/a

-US$56m

Mar 31 2022n/an/a

-US$51m

Dec 31 2021US$5mUS$525k

-US$43m

Sep 30 2021n/an/a

-US$36m

Jun 30 2021n/an/a

-US$27m

Mar 31 2021n/an/a

-US$21m

Dec 31 2020US$2mUS$425k

-US$17m

Dec 31 2019US$741kUS$425k

-US$10m

報酬と市場: Kevinの 総報酬 ($USD 3.98M ) は、 US市場 ($USD 6.54M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Kevinの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Kevin Koch (64 yo)

7.3yrs

在職期間

US$3,975,855

報酬

Dr. Kevin Koch, Ph.D. is a Venture Partner at OrbiMed Advisors, LLC. He has been a Member of Scientific Advisory Board at OnKure, Inc. Dr. Koch serves as a Member of Scientific Advisory Board at Frontier M...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Peter Thompson
Co-Founder & Independent Chairman7.5yrsUS$226.00k0%
$ 0
Kevin Koch
President7.3yrsUS$3.98m0.37%
$ 11.4m
Badreddin Edris
Co-Founder & Independent Director7.5yrsUS$193.00k0.021%
$ 638.1k
Behrad Derakhshan
Chief Business Officer4.2yrsUS$1.76m0.016%
$ 486.9k
Joanne Donovan
Chief Medical Officer3.6yrsUS$1.72m0.015%
$ 468.0k
Alan Russell
Co-Founder7.4yrsUS$2.46m0.013%
$ 409.5k
R. Carruthers
Chief Financial Officer4.2yrsUS$772.02k0.081%
$ 2.5m
John Moore
General Counsel4.2yrsデータなし0.0034%
$ 104.6k
Marc Semigran
Chief Development Officer1.9yrsデータなしデータなし

4.2yrs

平均在職期間

64yo

平均年齢

経験豊富な経営陣: EWTXの経営陣は 経験豊富 であると考えられます ( 4.2年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Peter Thompson
Co-Founder & Independent Chairman7.5yrsUS$226.00k0%
$ 0
Kevin Koch
President7.4yrsUS$3.98m0.37%
$ 11.4m
Badreddin Edris
Co-Founder & Independent Director3.8yrsUS$193.00k0.021%
$ 638.1k
Alan Russell
Co-Founder7.3yrsUS$2.46m0.013%
$ 409.5k
Jonathan Root
Independent Director5.3yrsUS$199.50k0.017%
$ 503.1k
Laura Brege
Independent Director3.9yrsUS$208.00k0%
$ 0
Arlene Morris
Directorless than a yearデータなしデータなし
Barry Byrne
Member of Scientific Advisory Boardno dataデータなしデータなし
Leslie Leinwand
Member of Scientific Advisory Boardno dataデータなしデータなし
Jonathan Fox
Independent Director1.7yrsUS$485.00k0.011%
$ 349.7k
Lee Sweeney
Member of Scientific Advisory Boardno dataデータなしデータなし
Craig McDonald
Member of the Scientific Advisory Board4.8yrsデータなしデータなし

4.8yrs

平均在職期間

64yo

平均年齢

経験豊富なボード: EWTXの 取締役会 は 経験豊富 であると考えられます ( 4.8年の平均在任期間)。